,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['trastuzumab', 'destiny-breast04', 'breast']
in anticipation of the results of destiny-breast04 being presented tomorrow, i thought i would share some information about fam-trastuzumab deruxtecan-nxki (t-dxd) and how it may differ from other her2-directed antibody drug conjugates in breast cancer, notably tdm-1.
Clinical Oncology Pharmacist @OHSUNews
Founder and President of Banyan Tree Clinics https://t.co/YXpxhLXWFu
Tweets and dog photos my own